Prevention of hospital-acquired hypokalemia in children receiving maintenance fluid therapy

Kazunari Kaneko, Ken Yoshimura, Takahisa Kimata, Kohsuke Ishii, Tetsuya Kitao, Sachiyo Tanaka, Shoji Tsuji

Department of Pediatrics, Kansai Medical University, Osaka, Japan.

DOI: 10.4236/ojped.2012.22023                

Abstract

Objective: It has been suggested that the use of hypotonic intravenous fluid (IVF) puts hospitalized children at a greater risk of developing hyponatremia in children with increased arginine vasopressin (AVP) production. To reduce its risk, the National Patient Safety Agency in UK issued alert 22 in 2007, of which recommendations were to use isotonic solutions for these children at risk of hyponatremia, instead of the previously most commonly used IVF (0.18% saline/ 4% dextrose) for maintenance fluid therapy. Recent observations, however, revealed that hypokalemia are also common in hospitalized patients who do not receive potassium in their IVF. This study was conducted to validate the potassium added IVF for the prevention of hospital-acquired hypokalemia in maintenance fluid therapy. Design: For maintenance fluid therapy, a commercially available IVF solution in Japan named as Solita-T2R (Na 84 mmol/L, K 20 mmol/L, Cl 66 mmol/L, glucose 3.2%) was infused for 41 sick children with a median age of 3.01 years. Its composition is close equivalent to 0.45% saline/5% dextrose (Na 77 mmol/L, K 0 mmol/L, Cl 77 mmol/L, dextrose 5%) except K content. The patients in states of AVP excess were excluded from the analysis. Results: Median serum potassium value did not drop significantly at a median interval of 48 hours (before IVF: 4.30 mmol/L, after IVF: 4.10 mmol/L, p > 0.05), whereas median serum sodium level significantly increased from 136.0 mmol/L to 139.0 mmol/L (p < 0.001). Conclusion: Potassium added (20 mmol/L) IVF solution reduces the risk of developing “hospital-acquired hypokalemia” in children who are not in states of AVP excess in maintenance fluid therapy. It is worthwhile to study prospectively in a larger number of sick children.

Keywords

Hyponatremia; Hypokalemia; Hypotonic Intravenous Fluid; Maintenance Fluid Therapy;Potassium Content

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Holliday, M.A. and Segar, W.E. (1957) The maintenance need for water in parenteral fluid therapy. Pediatrics, 19, 823-832.
[2]	Halberthal, M., Halperin, M.L. and Bohn, D. (2001) Lesson of the week: Acute hyponatraemia in children admitted to hospital: Retrospective analysis of factors contributing to its development and resolution. British Medical Journal, 322, 780-782. doi:10.1136/bmj.322.7289.780
[3]	Moritz, M.L. and Ayus, J.C. (2003) Prevention of hospital-acquired hyponatremia: A case for using isotonic saline. Pediatrics, 111, 227-230. doi:10.1542/peds.111.2.227
[4]	Moritz, M.L. and Carlos, A.J. (2007) Hospital-acquired hyponatremia—Why are hypotonic parenteral fluids still being used? Nature Clinical Practice Nephrology, 3, 374-382. doi:10.1038/ncpneph0526
[5]	Kaneko, K. (2010) Hospital-acquired hyponatremia in children: Epidemiology, pathophysiology, and prevention. Journal of Pediatric Biochemistry, 1, 39-44.
[6]	NPSA (2007) Reducing the risk of hyponatraemia when administering intravenous infusions to children. Alert no. 22, National Patient Safety Agency. http://www.nrls.npsa.nhs.uk/resources/?entryid45=59809&q=0%c2%ac2007%c2%ac&p=2
[7]	Kaneko, K. (2010) Don’t forget potassium! European Journal of Pediatrics, 169, 1041. doi:10.1007/s00431-010-1167-x
[8]	Kaneko, K., Shimojima, T. and Kaneko, K. (2004) Risk of exacerbation of hyponatremia with standard maintenance fluid regimens. Pediatric Nephrology, 19, 1185-1186. doi:10.1007/s00467-004-1559-0
[9]	Halperin, M.L. and Kamel, K.S. (1998) Potassium. Lancet, 352, 135-140.
[10]	Gennari, F.J. (1998) Hypokalemia. New England Journal of Medicine, 339, 451-458. doi:10.1056/NEJM199808133390707
[11]	Crop, M.J., Hoorn, E.J., Lindemans, J. and Zietse, R. (2007) Hypokalaemia and subsequent hyperkalaemia in hospitalized patients. Nephrology Dialysis Transplantation, 22, 3471-3477. doi:10.1093/ndt/gfm471
[12]	Armon, K., Riordan, A., Playfor, S., Millman, G., Khader, A. and Paediatric Research Society. (2008) Hyponatraemia and hypokalaemia during intravenous fluid administration. Archives of Disease in Childhood, 93, 285-287. doi:10.1136/adc.2006.093823
[13]	Moritz, M.L. and Ayus, J.C. (2010) New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children. Pediatric Nephrology, 25, 1225-1238. doi:10.1007/s00467-009-1323-6
[14]	Sharifi, J., Ghavami, F., Nowrouzi, Z., Fouladvand, B., Malek, M., Rezaeian, M. and Emami, M. (1985) Oral versus intravenous rehydration therapy in severe gastroenteritis. Archives of Disease in Childhood, 60, 856-860. doi:10.1136/adc.60.9.856
[15]	Assadi, F. and Copelovitch, L. (2003) Simplified treatment strategies to fluid therapy in diarrhea. Pediatric Nephrology, 18, 1152-1156. doi:10.1007/s00467-003-1303-1
[16]	Unwin, R.J., Luft, F.C. and Shirley, D.G. (2011) Pathophysiology and management of hypokalemia: A clinical perspective. Nature Reviews Nephrology, 7, 75-84. doi:10.1038/nrneph.2010.175